Announcement of awarded contract on the basis of Art. 266a, para. 5, item 3 of the Law on Medicinal Products in Human Medicine, in conjunction with Art. 1, para. 1, item 2, art. 3, para. 3, Art. 15c, para. 1 and Art. 15b of Ordinance No....

Announcement of awarded contract on the basis of Art. 266a, para. 5, item 3 of the Law on Medicinal Products in Human Medicine, in conjunction with Art. 1, para. 1, item 2, art. 3, para. 3, Art. 15c, para. 1 and Art. 15b of Ordinance No. 10/17.11.2011 of the Ministry of Health Announcement of awarded contract on the basis of Art. 266a, para. 5, item 3 of the Law on Medicinal Products in Human Medicine, in conjunction with Art. 1, para. 1, item 2, art. 3, para. 3, Art. 15c, para. 1 and Art. 15b of Ordinance No. 10/17.11.2011 of the Ministry of Health
Announcement of awarded contract on the basis of Art. 266a, para. 5, item 3 of the Law on Medicinal Products in Human Medicine, in conjunction with Art. 1, para. 1, item 2, art. 3, para. 3, Art. 15c, para. 1 and Art. 15b of Ordinance No. 10/17.11.2011 of the Ministry of Health. The contractor accepts, after receiving a letter of consent from the Medicines Executive Agency (EMA) and a written request for the delivery of the medicinal product listed below, to deliver the following medicinal product, in the quantities prescribed by UMBAL St. Ivan Rilski EAD with protocol - Appendix No. 1 (which is applicable), issued in accordance with Ordinance No. 10 / 17.11.2011, at the CONTRACTORs offer. - International non-proprietary name: 99mTcmethylenediphos phonate acid, MDP 5 mg, powder for solution for injection, Institute of Isotopes Co. LTD., powder for injection solution, lyophilized; each vial contains 5 mg of active substance, number of dosage forms in a package - 6 vials;